HomeEW • NYSE
Edwards Lifesciences Corp
$92.85
After Hours:
$92.85
(0.00%)0.00
Closed: Mar 18, 4:49:26 PM GMT-4 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$92.31
Day range
$91.95 - $93.04
Year range
$60.57 - $95.27
Market cap
55.83B USD
Avg Volume
4.74M
P/E ratio
40.35
Dividend yield
-
Primary exchange
NYSE
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
1.53B13.78%
Operating expense
572.80M-10.79%
Net income
369.90M-7.15%
Net profit margin
24.11-18.41%
Earnings per share
0.640.00%
EBITDA
641.10M32.54%
Effective tax rate
12.33%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
1.64B35.32%
Total assets
9.36B12.91%
Total liabilities
2.64B6.36%
Total equity
6.72B
Shares outstanding
601.30M
Price to book
8.35
Return on assets
16.13%
Return on capital
20.37%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
369.90M-7.15%
Cash from operations
136.60M-51.70%
Cash from investing
14.10M-85.11%
Cash from financing
-413.20M50.72%
Net change in cash
-265.90M44.50%
Free cash flow
100.65M-57.99%
About
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia
Founded
1958
Employees
19,800
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu